Hutch News
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 16, 2019
Improving HIV clinical trials with mobile technology
From the HIV Vaccine Trials Network, Vaccine and Infectious Disease Division
Enlisting the microbiome in the quest for an AIDS vaccine
We now know that microbial communities, especially in our guts, profoundly affect immune response
GMO malaria saves the day
Kublin Laboratory, Vaccine and Infectious Disease Division
On the path to a new-generation malaria vaccine
New approach using genetically modified parasite ‘primes the immune system’ in first human trial
'Roz and Ray': An HIV tragedy with lessons for today
Seattle Repertory drama, panel explore fallout from an early AIDS crisis in hemophiliacs
Good News: Dr. David Maloney named cellular immunotherapy medical director at Fred Hutch, SCCA; Dr. Jim Kublin gets grant to study how gut bugs alter HIV vaccine response
Celebrating faculty and staff achievements
First test of 'off-the-shelf' cord blood cell product outside the transplantation setting
Celebrating faculty and staff achievements
Getting malaria on purpose
Volunteers roll up their sleeves and get infected to test an experimental drug
Zika virus: 6 key things we don’t yet know
From lack of data to inconclusive blood tests to the unique challenges of pregnancy, experts weigh in on the knowledge gaps in this emerging infection
Charlie Sheen’s announcement reveals ‘ugly ogre underneath’ public awareness of HIV
Reactions underscore disease’s lingering stigma
Fantastic failures: Scientific setbacks fuel big gains
Whether solving the mysteries of outer space or cancer cells, many major advances followed messy moments
Gut microbiome may have interfered with experimental HIV vaccines
Inoculating infants instead of adults could bypass problem, researchers say
Finding a better way to take a bite out of malaria’s power
Fred Hutch and collaborators launch new trials to infect – and quickly treat – volunteers to test experimental drugs
Fred Hutchinson Cancer Research Center and Seattle BioMed team up on malaria clinical trials
Studies to test drugs that may be useful for malaria treatment and prevention
‘Angels in America’ cast visits Fred Hutch, learns about early days of AIDS
‘Angels in America’ cast visits Fred Hutch to hear about the early days of AIDS from those who were there
Intiman Theatre and Fred Hutch announce innovative partnership to raise awareness of HIV vaccine research during ‘Angels in America’
THE ANGELS PROJECT continues throughout summer
'Never give up': Researchers' tireless quest for HIV vaccines leads to Cape Town
HIV Vaccine Trials Network opens South African lab as it gears up to launch
HIV Vaccine Awareness Day May 18
Center's HIV Vaccine Trials Network and HIV research unit mark annual observance
HIV Vaccine Trials Network relaunches publication
Newsletter highlights clinical trial research, protocols in the field and the network's mission to drive the development of a safe, globally effective vaccine to prevent HIV
HVTN moves forward with Africa's first major HIV-vaccine trial
Three thousand South Africans may enroll in continent's first large-scale HIV-vaccine study
A deadly cycle of infection
<p>Study by PHS, Clinical Research divisions shows malaria may fuel spread of HIV while HIV may boost adult malaria-infection rates in Africa</p>
